SCHEMBL346282

SCHEMBL346282

[O]c1cccc2snnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15686693 0.75 GABRA1 (0.40) —
SCHEMBL4615662 0.74 F9 (0.30) —
SCHEMBL5355939 0.74 — —
SCHEMBL289346 0.74 ALDH1A1 (0.46) —
SCHEMBL29942154 0.74 BACE1 (0.35) —
SCHEMBL289345 0.74 — —
SCHEMBL3739493 0.72 ALDH1A1 (0.44) —
SCHEMBL5353984 0.72 MAPT (0.33) —
SCHEMBL28487213 0.71 NSD2 (0.33) —
SCHEMBL19328412 0.71 FBP1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111989317-B Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer, optical film, optically anisotropic body, and polarizing plate 日本瑞翁株式会社 2023-12-01 — — CN disclosed
US-11829036-B2 Optically anisotropic multilayer product and method for producing same ZEON CORPORATION (JP) 2023-11-28 — — US disclosed
WO-2023132369-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT 中外製薬株式会社 2023-07-13 — — WO disclosed
CN-111602077-B Composition, phase difference film, and method for producing phase difference film 日本瑞翁株式会社 2022-06-14 — — CN disclosed
CN-114424114-A Optically anisotropic multilayer body and method for producing same 日本瑞翁株式会社 2022-04-29 — — CN disclosed
CN-110392703-B Polymerizable compound and method for producing same, polymerizable composition, polymer, optical film, and optically anisotropic body 日本瑞翁株式会社 2022-02-01 — — CN disclosed
US-20210198574-A1 COMPOSITION, RETARDATION FILM, AND METHOD FOR PRODUCING RETARDATION FILM ZEON CORPORATION (JP) 2021-07-01 — — US disclosed
CN-111989317-A Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer, optical film, optically anisotropic body, polarizing plate, display device, and antireflection film 日本瑞翁株式会社 2020-11-24 — — CN disclosed
CN-111602077-A Composition, phase difference film, and method for producing phase difference film 日本瑞翁株式会社 2020-08-28 — — CN disclosed
US-20200262801-A1 POLYMERIZABLE COMPOUND AND A PRODUCTION METHOD FOR SAME, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICAILLY ANISOTROPIC BODY, POLARIZING PLATE, DISPLAY DEVICE, ANTIREFLECTION FILM, AND COMPOUND AND USE FOR SAME ZEON CORPORATION (JP) 2020-08-20 — — US disclosed
US-20060241171-A1 Novel physiologically active substances MICROBIOPHARM JAPAN CO., LTD. (JP) 2006-10-26 — — US disclosed
US-20060235002-A1 Novel physiologically active substance EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-10-19 — — US disclosed
EP-1710244-A1 METHOD OF STABILIZING MACROLIDE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2006-10-11 — — EP disclosed
EP-1705247-A1 DNA PARTICIPATING IN HYDROXYLATION OF MACROLIDE COMPOUND MERCIAN CORPORATION (JP) 2006-09-27 — — EP disclosed
US-20060009439-A1 Novel physiologically active substances MERCIAN CORPORATION (JP) 2006-01-12 — — US disclosed
US-20050245514-A1 Novel physiologically active substances MICROBIOPHARM JAPAN CO., LTD. (JP) 2005-11-03 — — US disclosed
US-20050227959-A1 Heterocyclic compound having oxime group EISAI CO., LTD. (JP) 2005-10-13 — — US disclosed
EP-1548121-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCES MERCIAN CORPORATION (JP) 2005-06-29 — — EP disclosed
EP-1541570-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCE MERCIAN CORPORATION (JP) 2005-06-15 — — EP disclosed
EP-1508570-A1 NOVEL PHYSIOLGICALLY ACTIVE SUBSTANCES MERCIAN CORPORATION (JP) 2005-02-23 — — EP disclosed
Send feedback